COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01235416
Brief Title: A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors

First Submitted : October 29, 2010
First Submitted that Met QC Criteria : November 4, 2010
First Posted : November 5, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : January 20, 2011
Last Update Posted : January 21, 2011 (Estimate)